Our goal is to improve the lives of others as much as we can. While our focus is grantmaking, what matters most to us is an organization’s potential for impact — not its tax status.
Good Ventures LLC, at the recommendation of the Open Philanthropy Project, invested in Sherlock Biosciences to support the development of a diagnostic platform to identify any human virus present in a patient sample.
Good Ventures LLC, at the recommendation of the Open Philanthropy Project, invested $5 million in EicOsis, a startup developing an oral treatment for neuropathic and inflammatory pain.
Good Ventures LLC, at the recommendation of the Open Philanthropy Project, invested $5.4 million in VasoRx, a startup developing a new therapy for vascular diseases such as atherosclerosis that are among the leading causes of death in the developed world.
In February 2018, Good Ventures LLC invested $14 million in the Dementia Discovery Fund, a venture capital fund investing in novel science to create new medicines for dementia, which affects more than 47 million people worldwide.
The Good Ventures Foundation, at the recommendation of the Open Philanthropy Project, invested in Impossible Foods to accelerate the development of its plant-based meats.
In August 2012, Good Ventures LLC led a $15M Series A round of investment in Vicarious FPC, an artificial intelligence company which uses the computational principles of the brain to build software that can think and learn like a human.